Search by Drug Name or NDC
NDC 51754-2131-04 MIDAZOLAM HYDROCHLORIDE 1 mg/mL Details
MIDAZOLAM HYDROCHLORIDE 1 mg/mL
MIDAZOLAM HYDROCHLORIDE is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Exela Pharma Sciences, LLC. The primary component is MIDAZOLAM HYDROCHLORIDE.
MedlinePlus Drug Summary
Midazolam injection is used before medical procedures and surgery to cause drowsiness, relieve anxiety, and prevent any memory of the event. It is also sometimes given as part of the anesthesia during surgery to produce a loss of consciousness. Midazolam injection is also used to cause a state of decreased consciousness in seriously ill people in intensive care units (ICU) who are breathing with the help of a machine. Midazolam injection is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow relaxation and decreased consciousness.
Related Packages: 51754-2131-04Last Updated: 02/05/2023
MedLinePlus Full Drug Details: Midazolam Injection
Product Information
| NDC | 51754-2131 |
|---|---|
| Product ID | 51754-2131_5aa322a4-0b10-4f41-ba56-508fc2b25229 |
| Associated GPIs | |
| GCN Sequence Number | 081276 |
| GCN Sequence Number Description | midazolam in NaCl,iso-osmot/PF VIAL 100MG/0.1L INTRAVEN |
| HIC3 | H22 |
| HIC3 Description | GENERAL ANESTHETICS,INJECTABLE-BENZODIAZEPINE TYPE |
| GCN | 48333 |
| HICL Sequence Number | 046695 |
| HICL Sequence Number Description | MIDAZOLAM IN SODIUM CHLORIDE, ISO-OSMOTIC/PF |
| Brand/Generic | Generic |
| Proprietary Name | MIDAZOLAM HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | MIDAZOLAM HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/mL |
| Substance Name | MIDAZOLAM HYDROCHLORIDE |
| Labeler Name | Exela Pharma Sciences, LLC |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | NDA |
| Application Number | NDA215868 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51754-2131-04 (51754213104)
| NDC Package Code | 51754-2131-4 |
|---|---|
| Billing NDC | 51754213104 |
| Package | 25 VIAL in 1 CARTON (51754-2131-4) / 100 mL in 1 VIAL |
| Marketing Start Date | 2022-12-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |